Evidence map›Paper›PMID 26663967›Full record

ArticleMedical journal, Armed Forces India2015

Trichosporon asahii urinary tract infection in immunocompetent patients.

Inam Danish Khan, Ajay Kumar Sahni, Atoshi Basu, Suboohi Haleem

Open access · bronzeAbstract read
In one paragraph

Article in Medical journal, Armed Forces India, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Trichosporon asahii causing subcutaneous mycoses in an immunocompetent patient: case report and a minireview.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Article
  5. Article
  6. Outbreak ofMedical journal, Armed Forces India · 2018
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Inam Danish KhanClinical Microbiologist, Dept of Pathology, Command Hospital (Eastern Command), Kolkata 700027, India.
Ajay Kumar SahniProfessor and Head, Dept of Microbiology, Armed Forces Medical College, Pune 411040, India.
Atoshi BasuSenior Advisor & Head, Dept of Pathology, Command Hospital (Eastern Command), Kolkata 700027, India.
Suboohi HaleemBiotechnologist, Martin & Harris Laboratories, New Delhi, India.
Command Hospital · INArmed Forces Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trichosporonosis is an emerging infection predominantly caused by Trichosporon asahii which is a ubiquitous and exclusively anamorphic yeast. T. asahii urinary tract infection is rare and remains scantily reported. T. asahii was isolated from urine of two immunocompetent patients who were receiving in-patient treatment for multiple comorbidities. T. asahii was identified phenotypically by a combination of manual and automated systems. Antifungal susceptibility done by E-test revealed multiresistance with preserved susceptibility to voriconazole. The ubiquity and biofilm formationposes difficulty in establishing pathogenicity and delineating environmental or nosocomial infections. Risk factors such as prolonged multiple antimicrobials, indwelling catheter and comorbidities such as anemia and hypoalbuminemia may be contributory to the establishment of a nosocomial opportunistic T. asahii infection. Dedicated efforts targeted at infection control are needed to optimize management and control of Trichosporon infections.

Indexed as

Antifungal multiresistanceNosocomial opportunistic infectionTrichosporon asahii

Identifiers

PMID26663967
PMCPMC4646908
OpenAlexW1990964378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.